News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,566 Results
Type
Article (73720)
Company Profile (455)
Press Release (692391)
Section
Business (211443)
Career Advice (3718)
Deals (37962)
Drug Delivery (104)
Drug Development (87943)
Employer Resources (189)
FDA (17517)
Job Trends (16398)
News (366800)
Policy (36719)
Tag
Academia (2962)
Africa (1115)
Alliances (53259)
Alzheimer's disease (1241)
Approvals (17432)
Arizona (179)
Artificial intelligence (86)
Asia (45308)
Australia (7943)
Bankruptcy (368)
Best Places to Work (12141)
Biosimilars (70)
Biotechnology (332)
C2C Services and Suppliers (85502)
California (1918)
Canada (919)
Cancer (510)
Career advice (3159)
Cell therapy (140)
China (152)
Clinical research (68469)
Collaboration (146)
Colorado (76)
Compensation (79)
Connecticut (75)
COVID-19 (2742)
Cystic fibrosis (77)
Data (286)
Diabetes (89)
Diagnostics (6449)
Drug pricing (81)
Earnings (79196)
Employer resources (161)
Europe (103408)
Events (119457)
Executive appointments (151)
FDA (17726)
Florida (266)
Funding (144)
Gene therapy (105)
GLP-1 (608)
Government (4949)
Healthcare (20457)
Hotbed/Location (503730)
Illinois (303)
Indiana (158)
Infectious disease (2772)
Inflammatory bowel disease (101)
Interviews (728)
IPO (17140)
Job creations (4412)
Job search strategy (2594)
Kansas (99)
Layoffs (462)
Legal (8699)
Lung cancer (121)
Manufacturing (94)
Maryland (414)
Massachusetts (1623)
Medical device (14023)
Medtech (14028)
Mergers & acquisitions (20658)
Metabolic disorders (287)
Michigan (134)
Minnesota (229)
Neuroscience (1402)
New Jersey (591)
New York (594)
NextGen Class of 2024 (7452)
Non-profit (5034)
North Carolina (685)
Northern California (827)
Obesity (172)
Ohio (109)
Opinion (234)
Patents (73)
Pennsylvania (578)
People (61685)
Pharmaceutical (85)
Phase I (21195)
Phase II (29864)
Phase III (22452)
Pipeline (107)
Postmarket research (3126)
Preclinical (9410)
Press Release (72)
Rare diseases (140)
Real estate (6772)
Recruiting (72)
Regulatory (24080)
Research institute (2619)
Resumes & cover letters (590)
South America (1495)
Southern California (752)
Startups (3968)
Texas (247)
United States (8951)
Vaccines (554)
Washington State (267)
Weight loss (161)
Date
Today (162)
Last 7 days (711)
Last 30 days (2320)
Last 365 days (39651)
2024 (27529)
2023 (42269)
2022 (53547)
2021 (58401)
2020 (57258)
2019 (50933)
2018 (38765)
2017 (36085)
2016 (36465)
2015 (42336)
2014 (36195)
2013 (32308)
2012 (34192)
2011 (34428)
2010 (33891)
766,566 Results for "american association for the advancement of science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
Theralase® Technologies Inc. announced that it is hosting Advisory Board meetings to present the latest Study II interim clinical data to its Principal Investigators at the Canadian Urological Association Bladder Cancer Forum and the American Urology Association, respectively.
March 26, 2024
·
5 min read
Biotech Bay
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced that results from the prevalence phase of its CATALYST study of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes were presented at the American Diabetes Association’s 84th Scientific Sessions.
June 24, 2024
·
5 min read
Drug Development
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association
Viking Therapeutics, Inc. today announced the presentation of preclinical data from a series of internally developed dual agonists of the amylin and calcitonin receptors at the 84th Scientific Sessions of the American Diabetes Association.
June 24, 2024
·
6 min read
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa) today announced its sponsorship of the American Heart Association’s new Addressing Recurrent Pericarditis initiative, a multi-faceted effort to improve quality of care through identification, dissemination, and implementation of best practices for the diagnosis and management of recurrent pericarditis.
June 17, 2024
·
6 min read
Genetown
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.
June 4, 2024
·
5 min read
BioCapital
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
Altimmune, Inc., a clinical-stage biopharmaceutical company, presented data on the effect of pemvidutide, its GLP-1/glucagon dual receptor agonist candidate in development for obesity and metabolic dysfunction-associated steatohepatitis, on cardioinflammatory lipids at the American Diabetes Association’s 84th Scientific Sessions.
June 22, 2024
·
5 min read
BioCapital
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
Altimmune, Inc. today announced oral presentations on pemvidutide, an investigational GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and MASH, at the American Diabetes Association’s (ADA) 84th Scientific Sessions, to be held in Orlando, FL from June 21-24, 2024.
June 18, 2024
·
2 min read
BioMidwest
The American Diabetes Association Names Winners of Diabetes Innovation Challenge
The American Diabetes Association ® announced the winners of its Innovation Challenge competition. Innovators showcased novel ideas for diabetes care before a panel of potential funders and an audience of professionals in the field, with the goal of furthering transformative solutions for people living with diabetes, their families, and caregivers.
June 22, 2024
·
3 min read
Biotech Bay
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants - June 03, 2024
Structure Therapeutics Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed underwritten public offering of 8,000,000 American depositary shares, each representing three ordinary shares.
June 3, 2024
·
5 min read
Genetown
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting
Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.
May 1, 2024
·
3 min read
1 of 76,657
Next